CBS 11 Header TXA 21 Header MeTV Header KRLD Header The Fan Header

News

Prostate Cancer Growth Slowed By Commonly Used Drug

View Comments

CBS DFW (con't)

Affordable Care Act Updates: CBSDFW.com/ACA

Health News & Information: CBSDFW.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

(CBS) – A drug that is commonly used to treat men with enlarged prostates may also delay the growth of prostate cancer, according to a new study.

The drug, dutasteride, works by blocking the conversion of testosterone to dihydrotestosterone, the male sex hormone implicated in the development of prostate cancer.

For the study – published in the January 24 online edition of The Lancet – 302 men ages 48 to 82 with low-risk localized prostate cancer were assigned either once daily dutasteride or a placebo for three years. Patients were given biopsies at 18 months and three years, and given a questionnaire about cancer-related anxiety.

The results showed that treatment with dutasteride significantly delayed prostate cancer progression – 38 percent versus 48 percent progression in those given the placebo.

Click here to read more about the study.

View Comments